(Q34623808)

3 August 2017

title

Inhaled corticosteroids and the risks of diabetes onset and progression (English)

1 reference

3 August 2017

Inhaled Corticosteroids and the Risks of Diabetes Onset and Progression (English)

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.06.019

20 July 2024

author name string

Samy Suissa

1

1 reference

3 August 2017

Abbas Kezouh

2

1 reference

3 August 2017

Pierre Ernst

3

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 October 2010

1 reference

full work available at URL

3 August 2017

https://api.elsevier.com/content/article/PII:S0002934310006480?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.06.019

https://api.elsevier.com/content/article/PII:S0002934310006480?httpAccept=text/plain

20 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.06.019

American Journal of Medicine

20 July 2024

published in

1 reference

3 August 2017

volume

123

1 reference

3 August 2017

issue

11

1 reference

3 August 2017

page(s)

1001-1006

1 reference

Inhaled corticosteroids in COPD: a case in favour

3 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.06.019

Inhaled corticosteroids in COPD: the case against

20 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.06.019

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

20 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.06.019

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

20 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.06.019

The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide

20 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.06.019

Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma

20 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.06.019

Association of inhaled corticosteroid use with cataract extraction in elderly patients.

20 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.06.019

Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis

20 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.06.019

Potential adverse effects of the inhaled corticosteroids

20 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.06.019

Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia

20 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.06.019

Epidemiology and costs of chronic obstructive pulmonary disease.

20 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.06.019

Trends in the epidemiology of COPD in Canada, 1980 to 1995. COPD and Rehabilitation Committee of the Canadian Thoracic Society.

20 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.06.019

The global burden of chronic diseases: overcoming impediments to prevention and control

20 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.06.019

Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD.

20 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.06.019

Chronic Obstructive Pulmonary Disease, Asthma, and Risk of Type 2 Diabetes in Women

20 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.06.019

Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease

20 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.06.019

Inhaled corticosteroids and the risk of diabetes among the elderly

20 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.06.019

Quantification of the Risk of Corticosteroid-induced Diabetes Mellitus Among the Elderly

20 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.06.019

The association of inhaled corticosteroid use with serum glucose concentration in a large cohort

20 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.06.019

Use of combination therapy in asthma: are they prescribed according to guidelines

20 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.06.019

Low-dose inhaled and nasal corticosteroid use and the risk of cataracts

20 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.06.019

Inhaled and Nasal Corticosteroid Use and the Risk of Fracture

20 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.06.019

Relationship between asthma severity and obesity

20 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.06.019

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease

20 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.AMJMED.2010.06.019

20 July 2024

Identifiers

1 reference

3 August 2017

1 reference